{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:39:18Z","timestamp":1763620758438,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00044-020-02583-8","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T04:28:22Z","timestamp":1591936102000},"page":"1187-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discovery of sultam-containing small-molecule disruptors of the huntingtin\u2013calmodulin protein\u2013protein interaction"],"prefix":"10.1007","volume":"29","author":[{"given":"Nicholas J.","family":"Klus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushboo","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Frankowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Muma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1049-5767","authenticated-orcid":false,"given":"Jeffrey","family":"Aub\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"2583_CR1","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1073\/pnas.93.10.5037","volume":"93","author":"J Bao","year":"1996","unstructured":"Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci USA 93:5037\u20135042","journal-title":"Proc Natl Acad Sci USA"},{"key":"2583_CR2","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1073\/pnas.1015269108","volume":"108","author":"S Basu","year":"2011","unstructured":"Basu S, Ellinger B, Rizzo S, Deraeve C, Sch\u00fcrmann M, Preut H, Arndt H-D, Waldmann H (2011) Biology-oriented synthesis of a natural-product inspired oxepane collection yields a small-molecule activator of the WNT-pathway. Proc Natl Acad Sci U S A 108:6805\u20136810","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2583_CR3","first-page":"18","volume":"95","author":"EG Berg","year":"2017","unstructured":"Berg EG (2017) First agents to fight Huntington\u2019s enter clinical trials. Chem Eng N. 95:18\u201320","journal-title":"Chem Eng N."},{"key":"2583_CR4","doi-asserted-by":"publisher","first-page":"6775","DOI":"10.1073\/pnas.1017666108","volume":"108","author":"LE Brown","year":"2011","unstructured":"Brown LE, Chih-Chien Cheng K, Wei W-G, Yuan P, Dai P, Trilles R, Ni F, Yuan J, MacArthur R, Guha R, Johnson RL, Su X-Z, Dominguez MM, Snyder JK, Beeler AB, Schaus SE, Inglese J, Porco JA (2011) Discovery of new antimalarial chemotypes through chemical methodology and library development. Proc Natl Acad Sci U S A 108:6775\u20136780","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2583_CR5","doi-asserted-by":"crossref","unstructured":"Cheung WY (1982) Role of calmodulin in brain function. In: Gispen WH and Routtenberg A (eds) Progress in brain research, vol 56. Elsevier, Amsterdam, pp 237\u2013253","DOI":"10.1016\/S0079-6123(08)63778-4"},{"key":"2583_CR6","doi-asserted-by":"publisher","first-page":"11550","DOI":"10.1523\/JNEUROSCI.3307-09.2009","volume":"29","author":"Y Dai","year":"2009","unstructured":"Dai Y, Dudek NL, Li Q, Fowler SC, Muma NA (2009) Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the r6\/2 mouse model of Huntington\u2019s disease. J Neurosci 29:11550\u201311559","journal-title":"J Neurosci"},{"key":"2583_CR7","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","volume":"22","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJL, Ratan RR, Beal MF, Hersch SM, Ferrante RJ (2002) Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease. J Neurosci 22:8942\u20138950","journal-title":"J Neurosci"},{"key":"2583_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/NEN.0b013e31816a9e60","volume":"67","author":"NL Dudek","year":"2008","unstructured":"Dudek NL, Dai Y, Muma NA (2008) Protective effects of interrupting the binding of calmodulin to mutant huntingtin. J Neutopathol Exp Neurol 67:355\u2013365","journal-title":"J Neutopathol Exp Neurol"},{"key":"2583_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1750-3639.2008.00258.x","volume":"20","author":"NL Dudek","year":"2010","unstructured":"Dudek NL, Dai Y, Muma NA (2010) Neuroprotective effects of calmodulin peptide 76-121aa: disruption of calmodulin binding to mutant huntingtin. Brain Pathol 20:176\u2013189","journal-title":"Brain Pathol"},{"key":"2583_CR10","doi-asserted-by":"crossref","unstructured":"Folk JE, Finlayson JS (1977) The \u025b-(\u03b3-glutamyl)lysine crosslink and the catalytic role of transglutaminases. In: Anfinsen CB, Edsall JT, Richards FM (eds) Advances in protein chemistry, vol 31. Academic Press, Cambridge, pp 1\u2013133","DOI":"10.1016\/S0065-3233(08)60217-X"},{"key":"2583_CR11","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.1073\/pnas.1016558108","volume":"108","author":"KJ Frankowski","year":"2011","unstructured":"Frankowski KJ, Setola V, Evans JM, Neuenswander B, Roth BL, Aub\u00e9 J (2011) Synthesis and receptor profiling of stemona alkaloid analogues reveal a potent class of sigma ligands. Proc Natl Acad Sci USA 108:6727\u20136732","journal-title":"Proc Natl Acad Sci USA"},{"key":"2583_CR12","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1136\/jnnp.2004.060186","volume":"76","author":"SM Hague","year":"2005","unstructured":"Hague SM, Klaffke S, Bandmann O (2005) Neurodegenerative disorders: Parkinson\u2019s disease and Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 76:1058\u20131063","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2583_CR13","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1073\/pnas.1015251108","volume":"108","author":"DM Huryn","year":"2011","unstructured":"Huryn DM, Brodsky JL, Brummond KM, Chambers PG, Eyer B, Ireland AW, Kawasumi M, LaPorte MG, Lloyd K, Manteau B, Nghiem P, Quade B, Seguin SP, Wipf P (2011) Chemical methodology as a source of small-molecule checkpoint inhibitors and heat shock protein 70 (hsp70) modulators. Proc Natl Acad Sci USA 108:6757\u20136762","journal-title":"Proc Natl Acad Sci USA"},{"key":"2583_CR14","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1073\/pnas.96.13.7388","volume":"96","author":"MV Karpuj","year":"1999","unstructured":"Karpuj MV, Garren H, Slunt H, Price DL, Gusella J, Becher MW, Steinman L (1999) Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington\u2019s disease brain nuclei. Proc Natl Acad Sci USA 96:7388","journal-title":"Proc Natl Acad Sci USA"},{"key":"2583_CR15","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1046\/j.1471-4159.1999.02018.x","volume":"73","author":"MCW Lesort","year":"1999","unstructured":"Lesort MCW, Jonson G, Ferrante R (1999) Tissue transglutaminase is increased in Huntington\u2019s disease brain. J Neurochem 73:2018\u20132027","journal-title":"J Neurochem"},{"key":"2583_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s42466-019-0039-8","volume":"1","author":"AP Marsh","year":"2019","unstructured":"Marsh AP (2019) Molecular mechanisms of proteinopathies across neurodegenerative disease: a review. Neurol Res Pract 1:35","journal-title":"Neurol Res Pract"},{"key":"2583_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/sj.cdd.4401093","volume":"9","author":"PG Mastroberardino","year":"2002","unstructured":"Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, Fesus L, Piacentini M (2002) \u2018Tissue\u2019 transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington\u2019s disease. Cell Death Differ 9:873\u2013880","journal-title":"Cell Death Differ"},{"key":"2583_CR18","first-page":"545","volume":"3","author":"D Paleacu","year":"2007","unstructured":"Paleacu D (2007) Tetrabenazine in the treatment of Huntington\u2019s disease. Neuropsychiatr Dis Treat 3:545\u2013551","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2583_CR19","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1016\/S0021-9258(17)36359-7","volume":"260","author":"EG Puszkin","year":"1985","unstructured":"Puszkin EG, Raghuraman V (1985) Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard. J Biol Chem 260:16012\u201316020","journal-title":"J Biol Chem"},{"key":"2583_CR20","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1016\/j.tet.2008.11.053","volume":"65","author":"DK Rayabarapu","year":"2009","unstructured":"Rayabarapu DK, Zhou A, Jeon KO, Samarakoon T, Rolfe A, Siddiqui H, Hanson PR (2009) \u0391-haloarylsulfonamides: multiple cyclization pathways to skeletally diverse benzofused sultams. Tetrahedron 65:3180\u20133188","journal-title":"Tetrahedron"},{"key":"2583_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1021\/jm00280a002","volume":"15","author":"JG Topliss","year":"1972","unstructured":"Topliss JG (1972) Utilization of operational schemes for analog synthesis in drug design. J Med Chem 15:1006\u20131011","journal-title":"J Med Chem"},{"key":"2583_CR22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1046\/j.1471-4159.1999.01871.x","volume":"73","author":"JKJ Tucholski","year":"1999","unstructured":"Tucholski JKJ, Johnson G (1999) Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J Neurochem 73:1871\u20131880","journal-title":"J Neurochem"},{"key":"2583_CR23","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1073\/pnas.91.12.5426","volume":"91","author":"EF Ullman","year":"1994","unstructured":"Ullman EF, Kirakossian H, Singh S, Wu ZP, Irvin BR, Pease JS, Switchenko AC, Irvine JD, Dafforn A, Skold CN et al. (1994) Luminescent oxygen channeling immunoassay: Measurement of particle binding kinetics by chemiluminescence. Proc Natl Acad Sci USA 91:5426\u20135430","journal-title":"Proc Natl Acad Sci USA"},{"key":"2583_CR24","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1523\/JNEUROSCI.4424-03.2004","volume":"24","author":"GM Zainelli","year":"2004","unstructured":"Zainelli GM, Ross CA, Troncoso JC, Fitzgerald JK, Muma NA (2004) Calmodulin regulates transglutaminase 2 cross-linking of huntingtin. J Neurosci 24:1954\u20131961","journal-title":"J Neurosci"},{"key":"2583_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnen\/62.1.14","volume":"62","author":"GM Zainelli","year":"2003","unstructured":"Zainelli GM, Ross CA, Troncoso JC, Muma NA (2003) Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J Neutopathol Exp Neurol 62:14\u201324","journal-title":"J Neutopathol Exp Neurol"},{"key":"2583_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/jnen\/64.1.58","volume":"64","author":"GM Zainelli","year":"2005","unstructured":"Zainelli GM, Dudek NL, Ross CA, Kim S-Y, Muma NA (2005) Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. J Neutopathol Exp Neurol 64:58\u201365","journal-title":"J Neutopathol Exp Neurol"},{"key":"2583_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/ol802467f","volume":"11","author":"A Zhou","year":"2009","unstructured":"Zhou A, Rayabarapu D, Hanson PR (2009) \u201cClick, click, cyclize\u201d: a DOS approach to sultams utilizing vinyl sulfonamide linchpins. Org Lett 11:531\u2013534","journal-title":"Org Lett"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-020-02583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-020-02583-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-020-02583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T13:12:40Z","timestamp":1723036360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-020-02583-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2583"],"URL":"https:\/\/doi.org\/10.1007\/s00044-020-02583-8","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"type":"print","value":"1054-2523"},{"type":"electronic","value":"1554-8120"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}